Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Senti Biosciences (SNTI)
NASDAQ:SNTI
Senti Biosciences (SNTI) Stock Price & Analysis
40 Followers
SNTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.86 - $9.65
Previous Close$0.88
Volume13.71K
Average Volume (3M)89.93K
Market Cap
$44.93M
Enterprise Value$5.66M
Total Cash (Recent Filing)$76.11M
Total Debt (Recent Filing)$37.92M
Price to Earnings (P/E)-0.4
Beta1.64
Next Earnings
Aug 14, 2023EPS Estimate
-$0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.08
Shares Outstanding44,168,034
10 Day Avg. Volume51,160
30 Day Avg. Volume89,928
Standard Deviation0.25
R-Squared0.29
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.38
Price to Sales (P/S)30.16
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.24
Enterprise Value/Gross Profit1.72
Enterprise Value/Ebitda-0.07
Forecast
1Y Price Target
$4.00Price Target Upside344.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Senti Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNTI FAQ
What was Senti Biosciences’s price range in the past 12 months?
Senti Biosciences lowest stock price was $0.86 and its highest was $9.65 in the past 12 months.
What is Senti Biosciences’s market cap?
Currently, no data Available
When is Senti Biosciences’s upcoming earnings report date?
Senti Biosciences’s upcoming earnings report date is Aug 14, 2023 which is in 73 days.
How were Senti Biosciences’s earnings last quarter?
Senti Biosciences released its earnings results on May 09, 2023. The company reported -$0.42 earnings per share for the quarter, beating the consensus estimate of -$0.433 by $0.013.
Is Senti Biosciences overvalued?
According to Wall Street analysts Senti Biosciences’s price is currently Undervalued.
Does Senti Biosciences pay dividends?
Senti Biosciences does not currently pay dividends.
What is Senti Biosciences’s EPS estimate?
Senti Biosciences’s EPS estimate is -$0.48.
How many shares outstanding does Senti Biosciences have?
Senti Biosciences has 44,168,034 shares outstanding.
What happened to Senti Biosciences’s price movement after its last earnings report?
Senti Biosciences reported an EPS of -$0.42 in its last earnings report, beating expectations of -$0.433. Following the earnings report the stock price went down -7.547%.
Which hedge fund is a major shareholder of Senti Biosciences?
Among the largest hedge funds holding Senti Biosciences’s share is ARK Investment Management LLC. It holds Senti Biosciences’s shares valued at 2M.
---
Senti Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (344.40% Upside)
$4.00 (344.40% Upside)
Hedge Fund Trend
Decreased
By 24.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.18%
12-Months-Change
Fundamentals
Return on Equity
-39.21%
Trailing 12-Months
Asset Growth
-30.09%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Senti Biosciences
Dynamics Special Purpose Corp is a blank check company.
---
Top 5 ETFs holding SNTI
ARK Genomic Revolution ETF
$1.60M
Vanguard Total Stock Market ETF
$310.24K
Up to five ETFs with an Outperform Smart Score that hold SNTI. The ETFs are listed according to market value of SNTI within the ETF
---
Crispr Therapeutics AG
―
Editas Medicine
―
Intellia Therapeutics
―
Beam Therapeutics
―
---